{"id":21521,"date":"2021-10-01T09:18:39","date_gmt":"2021-10-01T14:18:39","guid":{"rendered":"https:\/\/saluddigital.com\/?p=21521"},"modified":"2025-10-21T11:58:12","modified_gmt":"2025-10-21T17:58:12","slug":"ensayos-clinicos-descentralizados-prometen-ser-una-solucion-a-problemas-de-diversidad-etnica-en-la-investigacion-medica","status":"publish","type":"post","link":"https:\/\/saluddigital.com\/en\/plataformas-digitales\/ensayos-clinicos-descentralizados-prometen-ser-una-solucion-a-problemas-de-diversidad-etnica-en-la-investigacion-medica\/","title":{"rendered":"Decentralized clinical trials promise to be a solution to problems of ethnic diversity in medical research"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

A study published in JAMA Oncology collected information from 230 clinical trials for the development of anticancer drugs, and the race or ethnicity of the participants was only reported in 63% of them. <\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The medical community has a pending situation with clinical trials and diversity. Research published in JAMA Oncology<\/em> \u201cReporting Disparity and Racial Representation in Clinical Trials That Led to Cancer Drug Approvals from 2008 to 2018,\u201d Questions Reporting and Representation of Racial\/Ethnic Groups Used to Approval of Cancer Drugs by the US Food and Drug Administration.<\/p>

\u201cWe would want the representation of trial participants to reflect the disease population being studied or the group that is intended to use the product being studied. So I think that, at a minimum, that's what we would strive for in terms of the composition of the study population," said Samantha Artiga, vice president of racial equity and health policy at the Kaiser Family Foundation<\/em>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

During the McKinsey Digital Health Conference<\/em>, conducted in early September, medical researchers outlined various strategies to address this problem of lack of ethnic data for clinical trials that subsequently lead to drug approval.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Data is the solution<\/strong><\/p>

Conference panelists recognized that data collection is one of the most necessary parts of solving the problem, however, the way this collection occurs and the reporting structure on ethnicity, income and other social determinants of health have ample room for improvement.<\/p>

\u201cLarge data gaps remain, particularly by race and ethnicity, with a high proportion of unknown or missing data in all data sets. This is not something specific to clinical trial data, and there is a growing proportion of people who identify as multiracial, and that trend is only going to increase over time,\u201d Artiga explained.<\/p>

Through decentralized clinical trials, the scientific community has the opportunity to reach more patients and more areas. Thanks to the advancement of virtual monitoring technologies and tools, patient data can be captured from home. I think what's exciting is that (the pandemic) has accelerated things like telemedicine, remote clinical trials, decentralized trials," said Cassandra Hui, founder and CEO of Heal Mary<\/em>.<\/p>

In this way, decentralized trials that mix traditional testing techniques could be a viable solution.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t BIBLIOGRAPHY<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

MOBIHEALTH NEWS<\/strong><\/p>

https:\/\/www.mobihealthnews.com\/news\/big-data-decentralized-trials-may-help-fix-researchs-diversity-problem<\/a><\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

Estudio publicado en JAMA Oncology recolect\u00f3 informaci\u00f3n de 230 ensayos cl\u00ednicos para el desarrollo de medicamentos contra el c\u00e1ncer y la raza o etnia de los participantes solo se inform\u00f3 en 63% de ellos. La comunidad m\u00e9dica tiene una situaci\u00f3n pendiente con los ensayos cl\u00ednicos y la diversidad. La investigaci\u00f3n publicada en JAMA Oncology “Disparidad de los informes y la representaci\u00f3n racial en los ensayos cl\u00ednicos que llevaron a la aprobaci\u00f3n de medicamentos contra el c\u00e1ncer de 2008 a 2018”, cuestiona la presentaci\u00f3n de los informes y la representaci\u00f3n de grupos raciales\/\u00e9tnicos que se utilizaron para aprobar medicamentos oncol\u00f3gicos por parte de la Administraci\u00f3n de Medicamentos y Alimentos de EE.UU. \u201cQuerr\u00edamos que la representaci\u00f3n de los participantes del ensayo reflejara la poblaci\u00f3n de la enfermedad que se est\u00e1 estudiando o el grupo que est\u00e1 destinado a utilizar el producto que se est\u00e1 estudiando. As\u00ed que creo que, como m\u00ednimo, eso es por lo que nos esforzar\u00edamos en t\u00e9rminos de la composici\u00f3n de la poblaci\u00f3n del estudio\u201d, dijo Samantha Artiga, vicepresidenta de equidad racial y pol\u00edtica de salud de la Kaiser Family Foundation. Durante la McKinsey Digital Health Conference, realizada a principios de septiembre, m\u00e9dicos investigadores plantearon diversas estrategias para abordar este problema de falta de datos \u00e9tnicos para los ensayos cl\u00ednicos que posteriormente derivan en la aprobaci\u00f3n de medicamentos. Los datos son la soluci\u00f3n Los panelistas de la conferencia reconocieron que la recolecci\u00f3n de datos es una de las partes m\u00e1s necesarias para solucionar el problema, sin embargo, la forma en que se da esta recolecci\u00f3n y la estructura de los informes sobre etnia, ingresos y otros determinantes sociales de la salud tienen un amplio margen de mejora. \u201cA\u00fan existen grandes lagunas en los datos, particularmente por raza y etnia, con una alta proporci\u00f3n de datos desconocidos o faltantes en todos los conjuntos de datos. Esto no es algo espec\u00edfico de los datos de los ensayos cl\u00ednicos, y hay una proporci\u00f3n creciente de personas que se identifican como multirraciales, y esa tendencia solo aumentar\u00e1 con el tiempo\u201d, explic\u00f3 Artiga. A trav\u00e9s de los ensayos cl\u00ednicos descentralizados, la comunidad cient\u00edfica tiene la oportunidad de llegar a m\u00e1s pacientes y a m\u00e1s zonas. Gracias al avance de las tecnolog\u00edas y herramientas de monitoreo virtual, los datos de los pacientes pueden capturarse desde su hogar. Creo que lo emocionante es que (la pandemia) ha acelerado cosas como la telemedicina, los ensayos cl\u00ednicos remotos, los ensayos descentralizados\u201d, explic\u00f3 Cassandra Hui, fundadora y directora ejecutiva de Heal Mary. De esta forma, los ensayos descentralizados que mezclen t\u00e9cnicas de ensayos tradicionales, podr\u00edan ser una soluci\u00f3n viable. BIBLIOGRAF\u00cdA MOBIHEALTH NEWS https:\/\/www.mobihealthnews.com\/news\/big-data-decentralized-trials-may-help-fix-researchs-diversity-problem<\/p>","protected":false},"author":1,"featured_media":21523,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[156,3393,160,153,1418],"tags":[145],"class_list":["post-21521","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-big-data","category-inteligencia-artificial-y-ciencia","category-noticias","category-plataformas-digitales","category-resena-de-publicaciones-cientificas","tag-noticias"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts\/21521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/comments?post=21521"}],"version-history":[{"count":0,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts\/21521\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/media\/21523"}],"wp:attachment":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/media?parent=21521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/categories?post=21521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/tags?post=21521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}